Apple has issued threat notifications to iPhone users across over 150 countries, warning them of potential 'mercenary spyware ...

RONALD J. DEIBERT is Professor of Political Science and Director of the Citizen Lab at the University of Toronto Munk School ...

MOSCOW: An Australian man will stand trial on mercenary charges in Russian-occupied Lugansk, the eastern region’s Moscow-installed authorities said on Friday, the latest foreign soldier fighting ...

One way to save a little green and make ends meet could be to start your own garden at home. By planting fruits and vegetables at home, you’ll cash in on something tasty, healthy, and affordable. Matt ...

Snow ends Saturday with Easter Sunday looking much nicer. The Pinpoint Weather Alert Day continues as temperatures fall below freezing overnight Friday, which should help snow actually stick and ...

"Couldn't have asked for a better 5 years," Dunne said after her final meet with the Tigers C. Morgan Engel/NCAA Photos via Getty Livvy Dunne is saying goodbye to gymnastics. After the LSU Tigers ...

KALAMAZOO, MI -- Two more Western Michigan University students have had their legal residency terminated by President Donald Trump’s administration. Four students previously had their legal ...

It’s the end of an era: WaleMania is over. On Friday, the musician announced that he’ll be concluding his annual WrestleMania weekend event series after 10 years. “I hope everybody has a ...

“The decision not to extend the bilateral ceasefire does NOT imply the suspension or the end of the Peace Talks Table, it does NOT affect the recognition as representative members of the EMBF for this ...

We chatted with Dane Brugler of The Athletic to break down the tight ends in this draft class. Brugler can be found on X/Twitter @dpbrugler for his analysis. The Chargers tight end room is led by a ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...